EQUITIES
Robust. Fundamental. Dynamic.
Our teams exercise independent thought with high conviction, resulting in portfolios that we believe are well positioned to address our clients' challenges – all within robust risk control frameworks.
£188.8bn
Equities Assets Under Management
155
Equities Investment
Professionals
18
Average Years’ Financial
Industry Experience
As at 30 September 2025
£188.8bn |
155 |
18 |
As at 30 September 2025
We measure success by a single factor: client outcomes. As a pure asset manager, our sole mission is to deliver consistent long-term risk-adjusted returns that exceed our benchmarks and peers, regardless of the prevailing investment landscape.
Featured strategies
Equities Strategies
US
- US Concentrated Growth
- US Mid Cap Growth
- US Mid Cap Value
- US Research Core Equity
- US Research Growth Equity
- US Small Cap Growth
- US Small Cap Value
- US SMID Cap Growth
- US SMID Cap Value
Specialty
- Absolute Return Equity
- Biotechnology Innovation
- Global Life Sciences
- Global Property Equities
- Global Small Cap
- Global Sustainable Equity
- Global Technology and Innovation
- Global Technology Leaders
Emerging Markets
Europe
Asia Pacific
Insights
Playing the long game in biotech’s recovery
The biotech sector has rebounded from a sharp sell-off earlier this year and could deliver even more value to investors who know where to look.
Investing in tomorrow’s acronyms today: Time to rethink global equity allocations?
A different approach to global equities investing in new themes through high conviction stock picking balanced with optimised portfolio construction.
Global Perspectives: Weighing small- and mid-cap market tailwinds
AI adoption, reshoring trends, and M&A activity could create long-duration growth tailwinds for small- and mid-cap domestic firms.
Institutional Insights
Sign up to get relevant content delivered straight to your inbox.